Literature DB >> 15728580

Vanishingly low levels of Ess1 prolyl-isomerase activity are sufficient for growth in Saccharomyces cerevisiae.

Trent R Gemmill1, Xiaoyun Wu, Steven D Hanes.   

Abstract

Ess1 is an essential peptidylprolyl-cis/trans-isomerase in the yeast Saccharomyces cerevisiae. Ess1 and its human homolog, Pin1, bind to phospho-Ser-Pro sites within proteins, including the carboxyl-terminal domain (CTD) of Rpb1, the largest subunit of RNA polymerase II (pol II). Ess1 and Pin1 are thought to control mRNA synthesis by catalyzing conformational changes in Rpb1 that affect interaction of cofactors with the pol II transcription complex. Here we have characterized wild-type and mutant Ess1 proteins in vitro and in vivo. We found that Ess1 preferentially binds and isomerizes CTD heptad-repeat (YSPTSPS) peptides that are phosphorylated on Ser5. Binding by the mutant proteins in vitro was essentially normal, and the proteins were largely stable in vivo. However, their catalytic activities were reduced >1,000-fold. These data along with results of in vivo titration experiments indicate that Ess1 isomerase activity is required for growth, but only at vanishingly low levels. We found that although wild-type cells contain about approximately 200,000 molecules of Ess1, a level of fewer than 400 molecules per cell is sufficient for growth. In contrast, higher levels of Ess1 were required for growth in the presence of certain metabolic inhibitors, suggesting that Ess1 is important for tolerance to environmental challenge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728580     DOI: 10.1074/jbc.M412172200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Multiple roles for the Ess1 prolyl isomerase in the RNA polymerase II transcription cycle.

Authors:  Zhuo Ma; David Atencio; Cassandra Barnes; Holland DeFiglio; Steven D Hanes
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

Review 2.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

Review 3.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

4.  Serine phosphorylation and proline isomerization in RNAP II CTD control recruitment of Nrd1.

Authors:  Karel Kubicek; Hana Cerna; Peter Holub; Josef Pasulka; Dominika Hrossova; Frank Loehr; Ctirad Hofr; Stepanka Vanacova; Richard Stefl
Journal:  Genes Dev       Date:  2012-08-14       Impact factor: 11.361

5.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 6.  Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II.

Authors:  Karen M Arndt; Daniel Reines
Journal:  Annu Rev Biochem       Date:  2015-03-26       Impact factor: 23.643

7.  The structure of the Candida albicans Ess1 prolyl isomerase reveals a well-ordered linker that restricts domain mobility.

Authors:  Zhong Li; Hongmin Li; Gina Devasahayam; Trent Gemmill; Vishnu Chaturvedi; Steven D Hanes; Patrick Van Roey
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

Review 8.  Prolyl isomerases in gene transcription.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-10-31

9.  Small family with key contacts: par14 and par17 parvulin proteins, relatives of pin1, now emerge in biomedical research.

Authors:  Jonathan W Mueller; Peter Bayer
Journal:  Perspect Medicin Chem       Date:  2008-03-07

10.  The Ess1 prolyl isomerase is required for transcription termination of small noncoding RNAs via the Nrd1 pathway.

Authors:  Navjot Singh; Zhuo Ma; Trent Gemmill; Xiaoyun Wu; Holland Defiglio; Anne Rossettini; Christina Rabeler; Olivia Beane; Randall H Morse; Michael J Palumbo; Steven D Hanes
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.